Atossa Therapeutics, Inc.
ATOS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,692 | -$8,423 | -$6,718 | -$6,347 |
| Dep. & Amort. | $4 | $4 | $4 | $4 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $796 | $563 | $774 |
| Change in WC | $1,899 | -$481 | $192 | -$1,486 |
| Other Non-Cash | $784 | $845 | $0 | $4 |
| Operating Cash Flow | -$6,005 | -$7,259 | -$5,959 | -$7,051 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | $0 | -$9 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$7 | $0 | -$9 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $3,369 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $3,369 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6,012 | -$7,259 | -$5,968 | -$3,682 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $57,967 | $65,226 | $71,194 | $74,876 |
| End Cash | $51,955 | $57,967 | $65,226 | $71,194 |
| Free Cash Flow | -$6,012 | -$7,259 | -$5,968 | -$7,051 |